Guidance on how to evaluate biotech teams, technologies, and financial structures when considering early-stage investment.

An overview of regulatory frameworks that impact biotech startups and how these shape investment timelines and risks.

An investor-focused session featuring a select group of regional founders presenting science-based ventures seeking capital and strategic support.

We’re inviting a small group of new and seasoned investors to take part in a workshop designed to make life sciences investing in Kansas City clearer, easier, and more rewarding....

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A clear introduction to biotech as an investable asset class, grounded in both real-world impact and financial opportunity. You’ll understand how innovation moves from lab to market and where investors...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A practical look at where angel investors play across the biotech lifecycle, from early proof-of-concept to value inflection points. Learn how capital, timing, and strategic support influence outcomes in a...

A breakdown of how drugs move from discovery to commercialization, including clinical development, manufacturing, and exit pathways. You’ll see where value is created, where risk accumulates, and what it takes...

An examination of how medical devices are developed, regulated, and brought to market. The session highlights how clinical impact, usability, reimbursement, and cost structure influence adoption, scalability, and investor returns.

A look at how diagnostics and BioTools companies create value by enabling faster, more accurate insights across clinical care and research. Key drivers include biomarker relevance, throughput, regulatory pathways, and...